How much does a box of Rubicatin (Rubitidine) cost? Cost reference and pricing at the time of patient purchase

Rubinectedin (Lurbinectedin) is a new type of anti-tumor drug that is currently mainly used to treat highly malignant tumors such as small cell lung cancer. The drug acts on RNApolymerase II mechanically, blocking the transcription of tumor cells DNA, thereby inhibiting the growth of cancer cells. With the successful launch of its original drug in the country, many patients are concerned about its price and how to obtain it. However, as of2025, the domestic retail price of Rubicatin has not yet been clearly announced, and the specific pricing still needs to be based on the actual selling price released by hospitals or pharmacies.

Judging from the information currently available through public channels, the overseas price of Rubicon is relatively clear and relatively high. The price of the original research version (4mg/box) sold in Hong Kong is about 2 more than more than yuan, which belongs to the price range of high-end anti-cancer drugs. However, due to factors such as exchange rate fluctuations, circulation costs, and agent pricing, the price may fluctuate when the drug is actually purchased. It is recommended that patients confirm the final price through formal channels before purchasing to avoid mistaken purchases or unreasonable price increases.

In other overseas markets, Rubicon is more expensive. For example, the price of the US version of the original drug is as high as more than 90,000 yuan, which is a very high-priced anti-cancer drug; the price of the Singapore version is relatively lower, but it also reaches about 30,000 yuan. Although they are expensive, there are currently no generic drugs, which means that patients can almost only rely on original drugs when purchasing, and the cost of treatment is under great pressure.

Generally speaking, although Rubicatin has been launched in China, because the pricing has not yet been made public, patients are temporarily unable to benefit from medical insurance. Although purchasing drugs overseas provides a variety of options, the high drug prices pose a great burden to ordinary patients. There is currently no substitute for generic drugs. In the absence of alternatives, patients are advised to obtain medication advice from regular medical institutions and pay attention to the progress of subsequent medical insurance negotiations, or wait for a more affordable generic version to be launched.

Reference materials:https://www.zepzelca.com/